Fractyl Health, Inc. SEC filings GUTS

Fractyl Health, Inc. has 227 filings in SEC EDGAR's recent list, going back to Mar 21, 2013. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.

Fractyl Health, Inc. SEC filings
Form Description Filed Period
DEF 14A Proxy statement Aug 24, 2026 Aug 24, 2026
PRE 14A Preliminary proxy statement Aug 14, 2026 Sep 24, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Apr 23, 2026
DEF 14A Proxy statement Aug 25, 2025 Oct 3, 2025
PRE 14A Preliminary proxy statement Aug 15, 2025 Oct 3, 2025
DEFA14A Additional proxy material Apr 24, 2025 —
DEF 14A Proxy statement Apr 24, 2025 Jun 11, 2025

Showing 8 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
GUTS (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Burlington, MA
SEC filer status
, Emerging growth company
SEC CIK
1572616
Former names
Fractyl Laboratories Inc. (until Mar 19, 2020)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.